NO882763D0 - Humant apolipoprotein ai og variantform av samme uttrykt i escherichia coli. - Google Patents

Humant apolipoprotein ai og variantform av samme uttrykt i escherichia coli.

Info

Publication number
NO882763D0
NO882763D0 NO1988882763A NO882763A NO882763D0 NO 882763 D0 NO882763 D0 NO 882763D0 NO 1988882763 A NO1988882763 A NO 1988882763A NO 882763 A NO882763 A NO 882763A NO 882763 D0 NO882763 D0 NO 882763D0
Authority
NO
Norway
Prior art keywords
sequence
protein
humant
apolipoprotein
escherichia coli
Prior art date
Application number
NO1988882763A
Other languages
English (en)
Other versions
NO882763L (no
Inventor
Rolando Lorenzetti
Lucia Monaco
Marco Soria
Raffaele Palomba
Antonella Isacchi
Paolo Sarmientos
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of NO882763D0 publication Critical patent/NO882763D0/no
Publication of NO882763L publication Critical patent/NO882763L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/705—Fusion polypeptide containing domain for protein-protein interaction containing a protein-A fusion

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
NO882763A 1986-10-23 1988-06-22 Humant apolipoprotein ai og variantform av samme uttrykt i escherichia coli. NO882763L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868625435A GB8625435D0 (en) 1986-10-23 1986-10-23 Human apolipoprotein ai
PCT/EP1987/000621 WO1988003166A1 (en) 1986-10-23 1987-10-21 Human apolipoprotein ai and variant form of the same expressed in escherichia coli

Publications (2)

Publication Number Publication Date
NO882763D0 true NO882763D0 (no) 1988-06-22
NO882763L NO882763L (no) 1988-08-22

Family

ID=10606217

Family Applications (1)

Application Number Title Priority Date Filing Date
NO882763A NO882763L (no) 1986-10-23 1988-06-22 Humant apolipoprotein ai og variantform av samme uttrykt i escherichia coli.

Country Status (16)

Country Link
EP (1) EP0267703B1 (no)
JP (2) JP2706247B2 (no)
KR (1) KR890700163A (no)
CN (1) CN87107991A (no)
AT (1) ATE64619T1 (no)
AU (1) AU8230587A (no)
CZ (1) CZ761587A3 (no)
DE (1) DE3770915D1 (no)
ES (1) ES2044950T3 (no)
GB (1) GB8625435D0 (no)
IL (1) IL84229A0 (no)
NO (1) NO882763L (no)
PT (1) PT85977B (no)
WO (1) WO1988003166A1 (no)
YU (1) YU193887A (no)
ZA (1) ZA877911B (no)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8712540D0 (en) * 1987-05-28 1987-07-01 Ucb Sa Expression of human proapolipoprotein a-i
GB8717791D0 (en) * 1987-07-28 1987-09-03 Baralle F E Immunoassay method
IT1229996B (it) * 1989-04-20 1991-09-20 Cesare Sirtori Espressione di apolipoproteina ai e apolipoproteina ai-milano in lievito e composizioni farmaceutiche che contengono dette apolipoproteine.
AU662885B2 (en) * 1990-06-07 1995-09-21 Scripps Research Institute, The APO AI polypeptides, antibodies, and immunoassays
US5292646A (en) * 1991-02-06 1994-03-08 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
US5270181A (en) * 1991-02-06 1993-12-14 Genetics Institute, Inc. Peptide and protein fusions to thioredoxin and thioredoxin-like molecules
EP0516443A1 (en) * 1991-05-31 1992-12-02 Eli Lilly And Company Vectors and methods for assaying the regulation of apolipoprotein ai synthesis
WO1993000443A1 (en) * 1991-06-26 1993-01-07 Bio-Technology General Corp. Purification of recombinant apolipoprotein e from bacteria
US5408038A (en) * 1991-10-09 1995-04-18 The Scripps Research Institute Nonnatural apolipoprotein B-100 peptides and apolipoprotein B-100-apolipoprotein A-I fusion peptides
SE9103701D0 (sv) * 1991-12-13 1991-12-13 Kabi Pharmacia Ab Apolipoprotein
SE9203753D0 (sv) * 1992-12-11 1992-12-11 Kabi Pharmacia Ab Expression system for producing apolipoprotein ai-m
SE9500778D0 (sv) * 1995-03-03 1995-03-03 Pharmacia Ab Process for producing a protein
SE9603068D0 (sv) 1996-08-23 1996-08-23 Pharmacia & Upjohn Ab Process for purifying a protein
SE9603303D0 (sv) 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a protein
SE9603304D0 (sv) 1996-09-11 1996-09-11 Pharmacia & Upjohn Ab Process for purifying a compound
UA81216C2 (en) * 1999-06-01 2007-12-25 Prevention and treatment of amyloid disease
CA2428114C (en) 2000-11-10 2013-07-23 Proteopharma Aps Apolipoprotein analogues
WO2003026492A2 (en) 2001-09-28 2003-04-03 Esperion Therapeutics Inc. Prevention and treatment of restenosis by local administration of drug
US7052849B2 (en) 2001-11-23 2006-05-30 Syn X Pharma, Inc. Protein biopolymer markers predictive of insulin resistance
AP2006003578A0 (en) * 2003-10-20 2006-04-30 Esperion Therapeutics Inc Pharmaceutical formulations, methods and dosing regimens for the treatment and prevention of acute coronary syndromes.
WO2005097206A2 (en) 2004-04-06 2005-10-20 Cedars-Sinai Medical Center Prevention and treatment of vascular disease with recombinant adeno-associated virus vectors encoding apolipoprotein a-i and apolipoprotein a-i milano
US7759315B2 (en) 2005-03-09 2010-07-20 Csl Behring Ag Treatment of inflammatory conditions of the intestine
EP2465519B1 (en) 2007-03-01 2013-10-23 CSL Limited Treatment of endothelial dysfunction in diabetic patients
WO2011143362A1 (en) 2010-05-11 2011-11-17 Esperion Therapeutics, Inc. Dimeric oxidation-resistant apolipoprotein a1 variants
RU2017126088A (ru) 2011-02-07 2019-01-31 Серени Терапеутикс Холдинг С.А. Липопротеиновые комплексы и их получение и применения
CN112940090B (zh) * 2021-03-18 2023-02-24 广州康盛生物科技股份有限公司 耐受辐照灭菌及高效消毒的蛋白a免疫吸附介质

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE89314T1 (de) * 1985-02-13 1993-05-15 Scios Nova Inc Menschlicher metallothionein ii-promotor in saeugetierexpressionssystemen.

Also Published As

Publication number Publication date
JPH1052287A (ja) 1998-02-24
JP2706247B2 (ja) 1998-01-28
ZA877911B (en) 1988-04-25
NO882763L (no) 1988-08-22
YU193887A (en) 1989-06-30
PT85977B (en) 1990-01-19
IL84229A0 (en) 1988-03-31
DE3770915D1 (de) 1991-07-25
ES2044950T3 (es) 1994-01-16
CN87107991A (zh) 1988-09-21
JP2777126B2 (ja) 1998-07-16
CZ761587A3 (en) 1994-11-16
ATE64619T1 (de) 1991-07-15
KR890700163A (ko) 1989-03-10
JPH02500797A (ja) 1990-03-22
WO1988003166A1 (en) 1988-05-05
EP0267703B1 (en) 1991-06-19
GB8625435D0 (en) 1986-11-26
AU8230587A (en) 1988-05-25
EP0267703A1 (en) 1988-05-18
PT85977A (en) 1987-11-01

Similar Documents

Publication Publication Date Title
NO882763D0 (no) Humant apolipoprotein ai og variantform av samme uttrykt i escherichia coli.
DE69634726D1 (de) Menschliche ctla-8 und verwendung von ctla-8 ähnlichen proteinen
ATE215124T1 (de) Rekombinante tetc-fusionsprotein enthaltene impfstoffzusammensetzungen
DE69034100D1 (de) Verktorvermittelte genominsertion und expression von dna in bcg
ATE91722T1 (de) Pferde-gamma-interferon.
ATE103931T1 (de) Polypeptide aus vipergift und deren genexpression.
DE69331501D1 (de) Unterdrückung der Proliferation von T-Zellen mittels Peptidfragmenten des basischen Proteins aus Myelin
DK0434605T3 (da) Ny fremgangsmåde til fremstilling af ikke-fusioneret protein i E.coli
DE69432427D1 (de) Tomate xyloglukan endotransglykosylase
ATE136058T1 (de) Induzierbare expressionsvektoren
ATE68206T1 (de) Plasmidvektor und seine verwendung.
ATE216706T1 (de) Peptide des hiv-gag proteins, ihre herstellung und verwendung
ATE174963T1 (de) Klonierung und expression eines rhoptry- assoziierten proteins aus p. falciparum
DK1847607T3 (da) Antistoffer mod p51-protein
DK128687D0 (da) Proteiner samt deres fremstilling og anvendelse
DE60138885D1 (de) Polypeptide mit aktivität der stimulierung von neutrophilen
RU92016315A (ru) Вектор, плазмида, способ получения протеина и метаболита, бактерия, применение бактерии